Search

How should the EU respond to the movement in innovation-based research to the East? The UK think tank Demos has some suggestions.

Novo Nordisk is doing its bit to reverse the Danish brain drain, offering a number of “return” fellowships to attract highly qualified expatriates back to Denmark.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

European policymakers are largely to blame for the sorry state of innovation in Europe, according Microsoft’s chief research and strategy officer.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

The timing couldn’t have been worse. As the European Commission announces two new public/private research partnerships, it admits that its flagship partnership project - the ambitious Galileo satellite system - has crashed and burned.

Portugal takes the EU helm on 1 July - and is planning new measures to revitalize the "Lisbon Agenda" for high-tech growth, says tech-policy leader Carlos Zorrinho.

Europe now has a European Space Policy to direct its research programmes and activities and avoid duplication of effort between member states. The policy was formally adopted at the Competitiveness Council meeting on Tuesday 22 May.

A new report describes the spread of the "global innovation network" model.

Soon it won’t be possible to fund the huge enterprises of the leading pharma companies with a handful of blockbuster drugs. The only question is whether they can change and innovate in time.

The development agency Scottish Enterprise is teaming up with one of the US’s leading life science property specialists to develop Edinburgh BioQuarter.